T1	Concept 16 22	period
T2	Concept 7 15	epidemic
R1	has-property Arg1:T1 Arg2:T2	
T3	Concept 57 64	doctors
T4	Action 68 76	identify
T5	Concept 77 85	COVID-19
T6	Concept 86 95	pneumonia
T9	Concept 115 123	patients
T10	Concept 131 138	initial
T11	Concept 139 146	contact
R2	in-context Arg1:T6 Arg2:T5	
R3	target Arg1:T4 Arg2:T6	
R4	subject Arg1:T4 Arg2:T3	
R5	has-property Arg1:T11 Arg2:T10	
R6	in-time Arg1:T4 Arg2:T11	
T7	Concept 101 114	heart failure
R7	has-property Arg1:T9 Arg2:T7	
R8	in-context Arg1:T4 Arg2:T9	
T8	Concept 43 52	challenge
T12	Concept 37 42	great
R9	has-property Arg1:T8 Arg2:T12	
R10	has-property Arg1:T4 Arg2:T8	
R11	in-context Arg1:T8 Arg2:T1	
T13	Concept 171 179	COVID-19
T14	Concept 189 193	MERS
A1	Negated T14
T15	Concept 195 200	BtCoV
A2	Negated T15
T16	Concept 205 208	MHV
A3	Negated T16
T17	Concept 223 230	RT-LAMP
T18	Concept 231 240	reactions
T19	Concept 214 222	positive
T20	Action 241 251	indicating
T21	Concept 152 159	samples
R12	in-context Arg1:T13 Arg2:T21	
R13	in-context Arg1:T14 Arg2:T21	
R14	in-context Arg1:T15 Arg2:T21	
R15	in-context Arg1:T16 Arg2:T21	
T22	Concept 271 279	reaction
T23	Concept 284 292	COVID-19
R16	is-a Arg1:T17 Arg2:T18	
R17	has-property Arg1:T17 Arg2:T19	
T24	Action 210 213	had
R18	subject Arg1:T24 Arg2:T13	
R19	subject Arg1:T24 Arg2:T14	
R20	subject Arg1:T24 Arg2:T15	
R21	subject Arg1:T24 Arg2:T16	
R22	target Arg1:T24 Arg2:T17	
R23	entails Arg1:T24 Arg2:T20	
T25	Concept 252 263	specificity
R24	in-context Arg1:T22 Arg2:T23	
R25	target Arg1:T20 Arg2:T25	
R26	in-context Arg1:T25 Arg2:T22	
T26	Concept 347 355	patients
T27	Concept 361 370	pneumonia
T28	Concept 338 346	COVID-19
T29	Concept 380 383	low
A4	Emphasized T29
T30	Concept 384 391	account
T31	Concept 405 412	CD8 + T
T32	Concept 413 418	cells
T33	Concept 325 334	one-third
T34	Action 371 374	had
R27	in-context Arg1:T27 Arg2:T28	
T35	Concept 314 323	pneumonia
A5	Negated T35
R28	in-context Arg1:T27 Arg2:T26	
R29	in-context Arg1:T35 Arg2:T26	
R30	subject Arg1:T34 Arg2:T27	
R31	target Arg1:T34 Arg2:T30	
R32	has-property Arg1:T30 Arg2:T29	
T36	Concept 393 400	<190/ÂµL
R33	in-context Arg1:T29 Arg2:T36	
R34	in-context Arg1:T30 Arg2:T31	
R35	is-a Arg1:T31 Arg2:T32	
R36	has-property Arg1:T27 Arg2:T33	
R37	in-context Arg1:T33 Arg2:T35	
T37	Concept 434 442	COVID-19
T38	Action 443 450	affects
T39	Concept 482 487	youth
T40	Concept 495 502	elderly
R38	subject Arg1:T38 Arg2:T37	
R39	target Arg1:T38 Arg2:T39	
R40	target Arg1:T38 Arg2:T40	
T41	Concept 645 653	COVID-19
T42	Action 680 689	exhibited
T43	Concept 690 693	ARF
T44	Reference 511 516	study
T45	Concept 546 566	basic kidney disease
T46	Concept 529 537	patients
T47	Action 567 573	showed
T48	Concept 585 596	abnormality
T49	Concept 600 614	renal function
T50	Concept 626 641	hospitalization
R42	has-property Arg1:T46 Arg2:T45	
R41	subject Arg1:T47 Arg2:T46	
R43	target Arg1:T47 Arg2:T48	
R44	in-context Arg1:T48 Arg2:T49	
T51	Concept 577 584	obvious
R45	has-property Arg1:T48 Arg2:T51	
R46	in-time Arg1:T47 Arg2:T50	
R47	in-context Arg1:T50 Arg2:T41	
A6	Negated T45
A7	Negated T47
R48	in-context Arg1:T47 Arg2:T44	
T52	Concept 671 679	patients
A8	Negated T42
R49	subject Arg1:T42 Arg2:T52	
R50	target Arg1:T42 Arg2:T43	
R51	in-context Arg1:T42 Arg2:T44	
